Neurogene

Neurogene drops high-dose arm in Rett study after death
Pharmaphorum
Fri, 11/22/24 - 11:09 am
Neurogene
clinical trials
Rett Syndrome
patient death
gene therapy
NGN-401
Neurogene falls again on Rett gene therapy side effects
Pharmaphorum
Mon, 11/18/24 - 11:11 am
Neurogene
Rett Syndrome
clinical trials
gene therapy
Neurogene’s stock sinks after adverse event with Rett syndrome gene therapy
Clinical Trials Arena
Tue, 11/12/24 - 10:59 am
Neurogene
Rett Syndrome
gene therapy
clinical trials
Neurogene secures $200M ahead of anticipated study readout
BioPharma Dive
Mon, 11/4/24 - 06:55 pm
Neurogene
funding
Rett Syndrome
NGN-401
A cancer biotech’s collapse gives Neurogene a path to Wall Street
BioPharma Dive
Tue, 07/18/23 - 10:01 pm
Neurogene
gene therapy
reverse merger
Neoleukin
Neurogene Launches With $68.5 Million to Advance Gene Therapies for Rare Neurological Diseases
BioSpace
Tue, 02/12/19 - 12:07 pm
Neurogene
gene therapy
neurological disorders